BRIEF-Crispr Therapeutics Reports Q1 Loss Per Share $0.62 – Reuters
|
BRIEF-Crispr Therapeutics Reports Q1 Loss Per Share $0.62
Reuters May 8 (Reuters) – CRISPR Therapeutics AG: * CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS. * CRISPR THERAPEUTICS AG – ON TRACK TO BEGIN CTX001 CLINICAL STUDY IN HEMOGLOBINOPATHIES IN 2018. * CRISPR … |
